Real Isolates, LLC Awarded U.S. Patent for Extraction of Cannabinoids from Cannabis Smoke
Beverly, Mass. (October 24, 2022) – Real Isolates LLC, a private Greater Boston area biotech company is pleased to announce that it has been issued a patent by the United States Patent and Trademark Office for a novel method used to extract cannabinoids and other compounds from cannabis smoke. The extracted oil created by this method, sold and licensed under the brand name Smokenol™, is rich in common and rare cannabinoids and enables a new category of oral, topical, and inhaled cannabis products.
“Our solventless method is not just a simpler and safer alternative to CO2 or hydrocarbon extraction.” said Michiel Westerkamp, Real Isolates CEO. “The majority of experienced cannabis users prefer the effects of cannabis smoke to conventional edibles. This patented method allows hemp and cannabis product manufacturers to deliver edible, topical, and inhalable products that combine convenience, duration, and dose consistency with effects similar to those from smoking.”
The cannabinoid composition of the cannabis plant is transformed by the high heat necessary to generate smoke. Conventional cannabis extracts use low temperatures and do not contain the richer diversity and balance of cannabinoids found in Smokenol™ smoke extracts and cannabis smoke.
Real Isolates licenses this intellectual property to product manufacturers. Examples of hemp-derived topicals and tinctures can be found at www.ProfoundNaturals.com.
About Real Isolates, LLC
Based in Beverly, Mass., Real Isolates, LLC – founded in 2019 – is a family-owned biotech company at the forefront of developing innovative extraction methods from cannabis smoke. The team at Real Isolates specializes in endocannabinoid pharmacology and medicinal natural product chemistry and has developed novel technology that extracts cannabinoids from cannabis smoke. These extracts are used to manufacture wellness and nutraceutical products with uniquely effective active ingredients. Real Isolates’ brands include Smokenol Day™, a CBD forward cannabis smoke extract derived from hemp, Smokenol™ , a cannabis smoke extract derived from high THC cannabis, and Profound Naturals™, the brand under which hemp derived Smokenol Day™ CBD products are sold. Profound Naturals™ products include topicals and tinctures that are available in-store and online at ProfoundNaturals.com.
Zach Galasso| DPA Communications
firstname.lastname@example.org | 978.604.5423
Meet The Two Radical Scientists Using TikTok To Make Cannabis Education Accessible - FORBES, Jul 26, 2022
“It would have taken us both over 10 years in academia to teach that many students, and we did it in less than a year.”
By Real Isolates founders Andrew Westerkamp and Miyabe Shields and presented by Real Isolates Chief Scientist Dr. Miyabe Shield.
... "Most notably, the CBD isolate which was > 98% pure transformed into 18 separate peaks.
Dr. Miyabe Shields, Chief Scientific Officer (CSO) at Real Isolates recently gave a talk at Cannabis Grand Rounds presented by Pivital Edu. Dr. Shields discussed how the endocannabinoid system is involved in the regulation and dysregulation of mental health. These matters are particularly pressing following the COVID19 pandemic, as we’ve seen substantial increases in the diagnosis of anxiety and depressive disorders.
Real Isolates has developed a commercially viable pyrolytic extraction method to harvest cannabinoids and terpenes from cannabis smoke. These patent-pending formulations are rich in common and rare cannabinoids (including pyrocannabinoids and pyroterpenes) and enable a new category of oral, topical, and inhaled cannabis therapies.
Smokenol™ products are made under license from Real Isolates, LLC. Consumers and product manufacturers may learn more on the Smokenol.com site. For inquiries about IP licensing please contact Sales@Realisolates.com
Smokenol Sessions is a free cannabis education video resource with content for all backgrounds and abilities about cannabis and the endocannabinoid system.
Videos will range from beginner (no scientific background) to advanced (masters and/or PhD level content) and are created under the direction of Dr. Miyabe Shields, PhD, Chief Scientific Officer of Real Isolates LLC, co-inventor of Smokenol™, endocannabinoid system pharmacology expert, and cannabis patient.
Dr. Miyabe Shields, PHD has their PhD in pharmaceutical sciences and specializes in cannabinoid and endocannabinoid pharmacology. They will present at the American Chemical Society 2021 Conference in the section “Cannabis Derived Treatments for Specific Medical Conditions: Macromolecular Interactions and Justifications.” Dr. Shields will be discussing the therapeutic mechanisms of cannabis for mental health disorders.
Real Isolates LLC files PCT and US Patent application for our novel extraction method of plant and fungus material and novel chemical formulation of cannabinoids.
The PCT application allows Real Isolates to seek protection in most countries in the world. The PCT application and non-provisional US patent application, if granted, have the potential to give 20 years of patent protection for both the method and chemical formulation.